Shanghai Medicilon
Shanghai
About Shanghai Medicilon
Medicilon is an integrated contract research organization (CRO), providing comprehensive one-stop new drug R&D services for pharmaceutical enterprises and scientific research institutions around the world. Based on key links of drug R&D, we focus on the demand for innovation and the development of the global pharmaceutical industry. With our experience in serving domestic and foreign biomedical industries, we have built an integrated technical platform covering key technologies in drug discovery, pharmaceutical research, and preclinical research, in a bid to provide comprehensive preclinical new drug R&D for the global biomedical industry.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1,001 – 5,000
- Estimated revenue: $100K – $500K
- Total funding: $4.7M
- Funding stage: IPO
- Last round: Series B (Apr 2015)
- Ticker: sse:688202
- Website: medicilon.com
- Phone: +86 21 5859 1500
Industries & Categories
Biopharma, Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/shanghai-medicilon-181519 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.